Mohamed Eltaib Elmobark
Overview
Explore the profile of Mohamed Eltaib Elmobark including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
28
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gohal G, Moni S, Bakkari M, Elmobark M
J Clin Med
. 2024 Oct;
13(19).
PMID: 39407835
Asthma, a complex disease characterized by persistent airway inflammation, remains an urgent global health concern. We explored the critical role of allergic biomarkers and dysregulated immune system in asthma through...
2.
Moni S, Abdelwahab S, Mohan S, Riadi Y, Elmobark M, Areshyi R, et al.
Nanomedicine (Lond)
. 2024 Oct;
19(29):2447-2462.
PMID: 39381998
To develop and characterize doxorubicin-loaded sodium selenite nanoparticles (SSNP-DOX) and their surface attachment with cetuximab (mAb-SSNP-DOX). SSNP-DOX was formulated by gelation and then conjugated with cetuximab to form mAb-SSNP-DOX. Characterization...
3.
Moni S, Abdelwahab S, Jabeen A, Elmobark M, Aqaili D, Ghoal G, et al.
Vaccines (Basel)
. 2023 Nov;
11(11).
PMID: 38006036
Vaccination is a groundbreaking approach in preventing and controlling infectious diseases. However, the effectiveness of vaccines can be greatly enhanced by the inclusion of adjuvants, which are substances that potentiate...
4.
Bakkari M, Moni S, Alshammari A, Sultan M, Madkhali O, Almoshari Y, et al.
Vaccines (Basel)
. 2023 Feb;
11(2).
PMID: 36851333
The present study focused on demonstrating the induction of humoral and cell-mediated immunity through the establishment of a cytokine network. We hypothesized the anti-inflammatory, pro-inflammatory, and IgE antibody levels after...
5.
Bakkari M, Moni S, Alshammari A, Salawi A, Sultan M, Madkhali O, et al.
Vaccines (Basel)
. 2022 Jun;
10(6).
PMID: 35746563
Recombinant HBsAg-loaded docosahexaenoic acid nanovesicles were successfully developed, lyophilized (LRPDNV) and characterized for their physico-chemical properties. The zetapotential (ZP) of LRPDNV was -60.4 ± 10.4 mV, and its polydispersity (PDI)...
6.
Madkhali O, Moni S, Sultan M, Bukhary H, Ghazwani M, Alhakamy N, et al.
Sci Rep
. 2021 May;
11(1):9914.
PMID: 33972626
The purpose of this study was to develop a novel nano antibacterial formulation of dextran sulfate sodium polymer. The dextran sulfate sodium (DSS) nanoparticles were formulated with gelation technique. The...
7.
Moni S, Sultan M, Makeen H, Jabeen A, Sanobar S, Siddiqui R, et al.
Nat Prod Res
. 2019 Oct;
35(15):2569-2573.
PMID: 31631708
The present study aimed to explore the biocomponents of leaves through hot continuous percolation method using methanol as solvent. The spectral analysis by GC-MS and FTIR study demonstrated the presence...